Search for: "TEVA PHARMACEUTICALS USA, INC."
Results 381 - 400
of 482
Sorted by Relevance
|
Sort by Date
10 Mar 2010, 5:22 am
Teva Pharmaceuticals USA, Inc. et al (Patent Docs) [read post]
14 Mar 2014, 8:00 am
First up is Teva Pharmaceuticals USA, Inc. v. [read post]
1 Feb 2013, 9:42 am
Wyeth Pharmaceuticals, Inc. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
29 Jul 2022, 6:11 pm
Teva Pharmaceuticals USA, Inc., v. [read post]
21 Jun 2012, 11:46 am
Teva Pharmaceuticals USA, Inc. [read post]
2 Sep 2010, 10:51 am
Teva Pharmaceuticals USA, Inc., 566 F.3d 989 (Fed. [read post]
6 Oct 2014, 5:36 am
At Written Description, Lisa Larrimore Ouellette previews next week’s argument in Teva Pharmaceuticals v. [read post]
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
17 Mar 2020, 1:32 pm
One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) has been recalled by Teva Pharmaceuticals due to the presence of particulate matter. [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
11 Dec 2013, 7:55 pm
USA, Inc., 395 F.3d 1364, 1376 (Fed. [read post]
5 Dec 2014, 9:00 am
Teva Pharmaceuticals USA, Inc., 731 F.3d 918 (9th Cir. 2013). [read post]
8 Feb 2017, 3:09 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
27 Jun 2011, 8:41 am
” Certiorari stage documents: Opinion below (3d Circuit) Petition for certiorari Brief in opposition Petitioners’ supplemental brief Respondents’ supplemental brief Petitioners’ reply Amicus brief of TEVA Pharmaceuticals USA, Inc. [read post]
31 Dec 2011, 1:00 pm
C-4329; and Teva Pharmaceuticals, Inc. and Cephalon, Dkt. [read post]
21 Mar 2018, 1:34 pm
Une de ces unicités a récemment refait surface dans la décision du Federal Circuit dans Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc.: la mise en vente pouvant faire anticiper un dépôt de brevet américain. [read post]
25 Jun 2018, 7:51 am
Teva Pharmaceuticals USA: Whether, under federal patent law, an inventor’s sale of an invention to someone who is required to keep the invention confidential constitutes “prior art” for purposes of determining whether the invention is patentable. [read post]
16 Sep 2011, 8:17 am
Teva Pharmaceuticals USA, Inc., 2011 U.S. [read post]
1 Apr 2016, 8:22 am
Based upon a logical extension of Teva v. [read post]
